The Condensation of Collagen Leads to an Extended Standing Time and a Decreased Pro-inflammatory Tissue Response to a Newly Developed Pericardium-based Barrier Membrane for Guided Bone Regeneration

In Vivo. 2020 May-Jun;34(3):985-1000. doi: 10.21873/invivo.11867.

Abstract

Background/aim: A new manufacturing process has been established for the condensation of collagen derived from porcine pericardium to develop a new dental barrier membrane (CPM) that can provide a long barrier functionality. A native collagen membrane (PM) was used as control.

Materials and methods: Established in vitro procedures using L929 and MC3T3 cells were used for cytocompatibility analyses. For the in vivo study, subcutaneous implantation of both membrane types in 40 BALB/c mice and established histological, immuno histochemical and histomorphometrical methods were conducted.

Results: Both the in vitro and in vivo results revealed that the CPM has a biocompatibility profile comparable to that of the control membrane. The new CPM induced a tissue reaction including more M2-macrophages.

Conclusion: The CPM is fully biocompatible and seems to support the early healing process. Moreover, the new biomaterial seems to prevent cell ingrowth for a longer period of time, making it ideally suited for GBR procedures.

Keywords: Collagen membrane; Guided Bone Regeneration (GBR); degradation; macrophages; pericardium.

MeSH terms

  • Animals
  • Biocompatible Materials
  • Biomarkers
  • Bone Regeneration*
  • Collagen / metabolism*
  • Female
  • Fibroblasts
  • Guided Tissue Regeneration*
  • Immunohistochemistry
  • Macrophages / metabolism
  • Membranes, Artificial*
  • Mice
  • Pericardium
  • Proteolysis
  • Swine
  • Time Factors

Substances

  • Biocompatible Materials
  • Biomarkers
  • Membranes, Artificial
  • Collagen